Tools

LEADER 03804nam 2200577 i 4500

001 on1461763996;

003 OCoLC;

005 20250120152034.0;

006 m o d f ;

007 cr |||||||||||;

008 241017s2024 dcu ob f000 0 eng c;

024 8 a| 56-175q| (GPO jacket number);

035 a| (Sirsi) o1461763996;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 1020-C (online);

086 0 a| Y 4.J 89/1:118-87;

088 a| Serial no. 118-87 (United States. Congress. House. Committee on the Judiciary);

245 10 a| Follow the science? :b| oversight of the Biden COVID-19 administrative state response : hearing before the Subcommittee on the Administrative State, Regulatory Reform, and Antitrust, Committee on the Judiciary, House of Representatives, One Hundred Eighteenth Congress, second session, June 26, 2024.;

246 30 a| Oversight of the Biden COVID-19 administrative state response;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2024.;

300 a| 1 online resource (iv, 106 pages);

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| "Serial no. 118-87.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Dr. Philip R. Krause, MD, Former Deputy Director, FDA Office of Vaccines Research & Review; Dr. Jordan Vaughn, MD, ABIM, Foundation for Spike Protein, Long Covid, and Microvascular Research, Inc.; Aaron Siri, Esq., Siri & Glimstad LLP; Dr. Andrew T. Pavia, MD, Fellow of the American Academy of Pediatrics (FAAP), Fellow of the American College of Physicians (FACP), Fellow of the Infectious Diseases Society of America (FIDSA), George and Esther Gross Presidential Professor, Chief, Division of Pediatric Infectious Diseases, University of Utah; Director, Hospital Epidemiology Program, Primary Children's Hospital.;

518 a| Date of hearing: 2024-06-26.;

588 a| Description based on online resource; title from PDF title page (GovInfo, viewed Oct. 17, 2024).;

650 0 a| COVID-19 Pandemic, 2020-2023z| United States.=| ^A1418885;

650 0 a| COVID-19 (Disease)x| Government policyz| United States.=| ^A1407776;

650 0 a| COVID-19 vaccines.0| https://id.loc.gov/authorities/subjects/sh2022005580=| ^A1439797;

650 0 a| Vaccinesx| Government policyz| United States.=| ^A140104;

610 20 a| Centers for Disease Control and Prevention (U.S.)0| https://id.loc.gov/authorities/names/no93011529=| ^A351016;

610 10 a| United States.b| Food and Drug Administration.0| https://id.loc.gov/authorities/names/n80126147=| ^A1253;

650 7 a| Health.2| cgpa;

655 7 a| Legislative hearings.2| lcgft0| https://id.loc.gov/authorities/genreForms/gf2013025047;

776 08 i| Print version:a| United States. Congress. House. Committee on the Judiciary. Subcommittee on the Administrative State, Regulatory Reform, and Antitrust.t| Follow the science?w| (OCoLC)1461763669;

856 40 u| https://purl.fdlp.gov/GPO/gpo2339287| 0;

922 a| BIBCONEWb| 20241017;

922 a| PUBPOLTERMSb| 20241017;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6493044;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6493044-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 11/7/2024x| EDOCUMENTz| JERESOURCE;

Follow the science? : oversight of the Biden COVID-19 administrative state response : hearing before the Subcommittee on the Administrative State, Regulatory Reform, and Antitrust, Committee on the Judiciary, House of Representatives, One Hundred Eighteenth Congress, second session, June 26, 2024.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2024.
Description	1 online resource (iv, 106 pages)
Supplemental Content	https://purl.fdlp.gov/GPO/gpo233928
Subjects	Centers for Disease Control and Prevention (U.S.) United States. Food and Drug Administration. COVID-19 Pandemic, 2020-2023--United States. COVID-19 (Disease)--Government policy. --United States. COVID-19 vaccines. Vaccines--Government policy. --United States.

Portion of title	Oversight of the Biden COVID-19 administrative state response
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	"Serial no. 118-87."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Dr. Philip R. Krause, MD, Former Deputy Director, FDA Office of Vaccines Research & Review; Dr. Jordan Vaughn, MD, ABIM, Foundation for Spike Protein, Long Covid, and Microvascular Research, Inc.; Aaron Siri, Esq., Siri & Glimstad LLP; Dr. Andrew T. Pavia, MD, Fellow of the American Academy of Pediatrics (FAAP), Fellow of the American College of Physicians (FACP), Fellow of the Infectious Diseases Society of America (FIDSA), George and Esther Gross Presidential Professor, Chief, Division of Pediatric Infectious Diseases, University of Utah; Director, Hospital Epidemiology Program, Primary Children's Hospital.
Date/time/place of a event note	Date of hearing: 2024-06-26.
Source of description	Description based on online resource; title from PDF title page (GovInfo, viewed Oct. 17, 2024).
Issued in other form	Print version: United States. Congress. House. Committee on the Judiciary. Subcommittee on the Administrative State, Regulatory Reform, and Antitrust. Follow the science?
Genre/form	Legislative hearings.
Standard identifier#	56-175 (GPO jacket number)
Technical rpt number	Serial no. 118-87 (United States. Congress. House. Committee on the Judiciary)
GPO item number	1020-C (online)
Govt. docs number	Y 4.J 89/1:118-87

Follow the science? : oversight of the Biden COVID-19 administrative state response : hearing before the Subcommittee on the Administrative State, Regulatory Reform, and Antitrust, Committee on the Judiciary, House of Representatives, One Hundred Eighteenth Congress, second session, June 26, 2024.

Click here for more information about this title